AHA Media

MANDATORY TESTING LIMITS, QUALITY ASSURANCE & CONTROL

In this video: Av Singh, Dr. John Coleman, Dr. Brigitte Simons, Jodi McDonald, Dr. Kaveh Kahen, Barinder Rasode

The stringency of the Canadian Cannabis Act enforcing product compliance to set testing guidelines is being evaluated by the global marketplace. In this session, industry leaders will talk about the challenges and tactical execution of how products are tested and reported to pass compliance for lot release. There is opportunity to minimize risk in the analytical variance of cannabis product testing between labs and to better understand standardization for potency, pesticide quantification and trace contaminant investigations lending to higher value product development. Our experts will impart a series of “frequently asked questions” and solutions that will lend to practical information to increase your ability to stay within the regulatory lines, and give your customers a quality assured product. Moderated by: Av Singh

Panelists:

Av Singh
Cannabis Cultivation Advisor, Flemming & Singh Cannabis Inc., Chief Science Officer, Green Gorilla

Dr. John Coleman
Co-Founder & President, Anandia

Dr. Brigitte Simons
VP of Laboratories and Operations, Molecular Science Corp

Jodi McDonald
Founder & President, Keystone Labs

Dr. Kaveh Kahen
Co-Founder and CEO, Sigma Analytical Services

Barinder Rasode
Founder, NICHE, CEO, Grow Tech Labs

CBD: THE CANNABIS INDUSTRY GAME-CHANGER?

In this video: Av Singh, Dr. Igor Kovalchuk, Tim Phillips, Megan Henderson

It’s cannabis without the high, but with all the analgesic and anti-inflammatory properties. And it opens the business up to markets far beyond the already robust existing one. This session will offer insights into the exponential growth of the THC-free analgesic product throughout the Western world, in everything from pet supplements to human health products. Is CBD a true “disruptor” to the pharmaceutical industry and others? How do its regulations vary across jurisdictions? If medical-sounding claims are made, will that invite more regulation? And with countless brands and competitors, what will the eventual shakedown look like? You’ve got questions, we’ve got answers. Moderated By: Megan Henderson

Panelists:

Megan Henderson
Executive Producer, TheGrowthOp

Av Singh
Cannabis Cultivation Advisor, Flemming & Singh Cannabis Inc., Chief Science Officer, Green Gorilla

Dr. Igor Kovalchuk
Corporate Director @ Kanata Earth , Professor / Plant Biotechnology Laboratory @ University of Lethbridge

Tim Phillips
Managing Director, CBD Intel

THE FUTURE OF CANNABIS CURRENCY

In this video: Daniel Sax, Hafeez Noorani, Amanda de Freitas, Meris Kott, Dan Reitzik, Tylor Johnson

It’s a function of that old black market that the cannabis trade traditionally involved cash. But a business that is legal and out of the shadows needs complete financial transparency to cement its legitimacy. Blockchain, the electronic ledger that made cryptocurrencies like Bitcoin possible, holds great promise. The ability to digitally track supply chains, sales and transactions is the kind of innovation that allows bankers and money managers to sleep at night. This panel will consider it, and a list of other financial trial balloons – including Cannabis Business Credit Unions – as approaches to building a healthy investment environment. Moderated By: Daniel Sax

Panelists:

Daniel Sax
Founder & CEO, Sensi Properties Ltd.

Hafeez Noorani
Chief Marketing Officer, Litly Technologies Inc.

Amanda de Freitas
CEO, Cannaceutical Canada Ltd

Meris Kott
CEO, Redfund Capital Corp

Dan Reitzik
Founder & CEO, DMG Blockchain

Tylor Johnson
Partner, Panda Solutions

THE EXTRACTION BOOM: HOW SCIENCE AND BUSINESS ARE CHANGING HOW WE USE CANNABIS

In this video: AC Braddock, Randy Reed, Chantel Popoff, Rosy Mondin, Phil Kwong, Ivan Casselman

As legal, adult-use cannabis markets become established and begin to mature, there is a departure from traditional cannabis consumption patterns such as smoking. Health concerns, social stigma and shifting consumer preference are driving a surge in demand for the production of differentiated cannabis consumables. Extraction technology – and how extracts are formulated – play a key role in the development of products that appeal to the next generation of cannabis consumer. There is an ever-increasing array of options within extraction technology, but do all stakeholders share cohesive goals? From producers, to manufacturers, formulators, and consumers, cannabis is a rapidly changing and, at times, confusing market sector. Supercritical carbon dioxide or ethanol extraction? Whole plant extracts or distillate oil? Let us help you make sense of it all. This panel will delve into the complexities of extraction technology, the risk and rewards of setting up an extraction facility, and the challenges of formulating extracted cannabis into edible products or beverages with market appeal and scalability. The panelists have a range of expertise including growing cannabis, the manufacturing of extraction equipment, commissioning and set up of extraction facilities, and the formulation, development and marketing of consumer products. Join us for a lively discussion on the art and economics of cannabis extraction. Moderated By: Ivan Casselman

Panelists:

Ivan Casselman
Director of Research and Development, Nextleaf Solutions

AC Braddock
USA, Eden Labs

Randy Reed
President, Olala

Chantel Popoff
Vice President of Valens Agritech Ltd., Valens GroWorks

Rosy Mondin
CEO, Quadron Cannatech

Phil Kwong
Founder, 3 Carbon Extractions